TsarTsar444
Asexual peaceful balkan monk
- Joined
- May 5, 2019
- Posts
- 41,593
- Reputation
- 105,779
"If MindMed is successful in bringing these psychedelic-inspired medicines for addiction and ADHD to market — and it should be — the potential upside in MindMed stock is enormous.
Worldwide pharma sales for opioid abuse totaled $2.9 billion in 2019. Worldwide pharma sales for ADHD totaled $9.2 billion in 2019. In sum, then, MindMed is an $80 million company disrupting a $12.1 billion market with novel, breakthrough treatments."
Thoughts?